Multiple Myeloma Resources
Chosen by Advanced
Practice Providers
  • Clinical guidelines
  • Patient support and education resources
  • Research updates

Patients With Smoldering Multiple Myeloma Report Symptoms and Quality of Life Impacts

This qualitative study explored the health-related quality of life (HRQoL) and symptom burden in patients with smoldering multiple myeloma (SMM), a precursor to multiple myeloma (MM) traditionally considered...
CURATED BY: Jill N. Burke,
CNP, DipACLM
Read More
Picture of Jill N. Burke,
Jill N. Burke,
CNP, DipACLM
Nurse Practitioner, Massachusetts General Hospital

Venetoclax Effective in t(11;14) Myeloma, but Impacted by High-Risk Cytogenetics

Multiple myeloma (MM) remains incurable despite advances in treatment, driving interest in novel therapies for relapsed/refractory cases....
CURATED BY:
Danielle Roberts,
MS, MMSc, PA-C
Read More >

Optimizing Bone Protection in Multiple Myeloma

In multiple myeloma (MM), bone disease is a major source of morbidity, making bone-protective agents like zoledronic acid (ZOL) and denosumab essential to care....
CURATED BY:
Danielle Roberts,
MS, MMSc, PA-C
Read More >

FDA Endorses MRD as Surrogate Endpoint to Accelerate Myeloma Drug Approvals

The FDA’s recent acceptance of minimal residual disease (MRD) negativity as a surrogate endpoint for accelerated approval in multiple myeloma (MM) represents a major advancement in clinical trial design and...
CURATED BY:
Donna D. Catamero,
ANP-BC, OCN, CCRC
Read More >

Nurse Practitioner and Physician Associate Contributors to the Multiple Myeloma Center of Excellence

POCN’s Multiple Myeloma Center of Excellence is curated by nurse practitioners and practicing clinical physician associates who review and select resources that are the most useful to their peers. They provide their expertise by hand-picking the latest content for advanced practice providers.

Provided by an unrestricted grant from

Privacy Policy
Your Privacy Choices
Terms of Use
Company
Contact
Partner with Us
Ambassador Program

© 2025 POCN—an IQVIA business. All Rights Reserved.

Share